熱門資訊> 正文

MannKind首席执行官购买10万股;股价攀升

2026-03-11 22:00

曼恩凱德生物醫療(MNKD) 0

MannKind(MNKD) chief executive officer and director, Michael Castagna reported buying 100,000 shares of company stock.
The shares were purchased on March 10, 2026, at a price of $2.59 per share.
The transaction increased Castagna’s direct ownership to 2.58M shares.
MNKD shares up 7.7%.

More on MannKind

Furoscix Growth Versus Tyvaso Royalties: Assessing MannKind's Future
MannKind Corporation 2025 Q4 - Results - Earnings Call Presentation
MannKind Corporation (MNKD) Q4 2025 Earnings Call Transcript
MannKind outlines $450M 2026 revenue run rate and key product catalysts amid Afrezza pediatric launch preparations
MannKind hits 52-week low after Q4 earnings miss

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。